IBDEI0RE ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,13209,1,4,0)
 ;;=4^733.22
 ;;^UTILITY(U,$J,358.3,13210,0)
 ;;=733.21^^65^784^6
 ;;^UTILITY(U,$J,358.3,13210,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13210,1,3,0)
 ;;=3^Bone Cyst, Solitary
 ;;^UTILITY(U,$J,358.3,13210,1,4,0)
 ;;=4^733.21
 ;;^UTILITY(U,$J,358.3,13211,0)
 ;;=250.00^^65^784^11
 ;;^UTILITY(U,$J,358.3,13211,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13211,1,3,0)
 ;;=3^Diabetes 
 ;;^UTILITY(U,$J,358.3,13211,1,4,0)
 ;;=4^250.00
 ;;^UTILITY(U,$J,358.3,13212,0)
 ;;=250.01^^65^784^12
 ;;^UTILITY(U,$J,358.3,13212,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13212,1,3,0)
 ;;=3^Diabetes Insulin Dependent
 ;;^UTILITY(U,$J,358.3,13212,1,4,0)
 ;;=4^250.01
 ;;^UTILITY(U,$J,358.3,13213,0)
 ;;=782.3^^65^784^13
 ;;^UTILITY(U,$J,358.3,13213,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13213,1,3,0)
 ;;=3^Edema
 ;;^UTILITY(U,$J,358.3,13213,1,4,0)
 ;;=4^782.3
 ;;^UTILITY(U,$J,358.3,13214,0)
 ;;=729.6^^65^784^15
 ;;^UTILITY(U,$J,358.3,13214,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13214,1,3,0)
 ;;=3^Foreign Body, Soft Tissue
 ;;^UTILITY(U,$J,358.3,13214,1,4,0)
 ;;=4^729.6
 ;;^UTILITY(U,$J,358.3,13215,0)
 ;;=709.4^^65^784^14
 ;;^UTILITY(U,$J,358.3,13215,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13215,1,3,0)
 ;;=3^Foreign Body Granul-Skin
 ;;^UTILITY(U,$J,358.3,13215,1,4,0)
 ;;=4^709.4
 ;;^UTILITY(U,$J,358.3,13216,0)
 ;;=785.4^^65^784^17
 ;;^UTILITY(U,$J,358.3,13216,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13216,1,3,0)
 ;;=3^Gangrene
 ;;^UTILITY(U,$J,358.3,13216,1,4,0)
 ;;=4^785.4
 ;;^UTILITY(U,$J,358.3,13217,0)
 ;;=440.24^^65^784^18
 ;;^UTILITY(U,$J,358.3,13217,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13217,1,3,0)
 ;;=3^Gangrene W/Atherosclerosis
 ;;^UTILITY(U,$J,358.3,13217,1,4,0)
 ;;=4^440.24
 ;;^UTILITY(U,$J,358.3,13218,0)
 ;;=342.90^^65^784^20
 ;;^UTILITY(U,$J,358.3,13218,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13218,1,3,0)
 ;;=3^Hemiplegia, Unsp side
 ;;^UTILITY(U,$J,358.3,13218,1,4,0)
 ;;=4^342.90
 ;;^UTILITY(U,$J,358.3,13218,2)
 ;;=^303267
 ;;^UTILITY(U,$J,358.3,13219,0)
 ;;=733.81^^65^784^27
 ;;^UTILITY(U,$J,358.3,13219,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13219,1,3,0)
 ;;=3^Malunion Fracture
 ;;^UTILITY(U,$J,358.3,13219,1,4,0)
 ;;=4^733.81
 ;;^UTILITY(U,$J,358.3,13220,0)
 ;;=733.82^^65^784^30
 ;;^UTILITY(U,$J,358.3,13220,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13220,1,3,0)
 ;;=3^Nonunion Fracture
 ;;^UTILITY(U,$J,358.3,13220,1,4,0)
 ;;=4^733.82
 ;;^UTILITY(U,$J,358.3,13221,0)
 ;;=729.1^^65^784^29
 ;;^UTILITY(U,$J,358.3,13221,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13221,1,3,0)
 ;;=3^Myalgia/Myositis 
 ;;^UTILITY(U,$J,358.3,13221,1,4,0)
 ;;=4^729.1
 ;;^UTILITY(U,$J,358.3,13222,0)
 ;;=732.7^^65^784^33
 ;;^UTILITY(U,$J,358.3,13222,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13222,1,3,0)
 ;;=3^Osteochondrit Dissecans
 ;;^UTILITY(U,$J,358.3,13222,1,4,0)
 ;;=4^732.7
 ;;^UTILITY(U,$J,358.3,13223,0)
 ;;=756.51^^65^784^34
 ;;^UTILITY(U,$J,358.3,13223,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13223,1,3,0)
 ;;=3^Osteogenesis Imperfecta
 ;;^UTILITY(U,$J,358.3,13223,1,4,0)
 ;;=4^756.51
 ;;^UTILITY(U,$J,358.3,13224,0)
 ;;=996.78^^65^784^23
 ;;^UTILITY(U,$J,358.3,13224,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13224,1,3,0)
 ;;=3^Internal Ortho Device, Oth Comp
 ;;^UTILITY(U,$J,358.3,13224,1,4,0)
 ;;=4^996.78
 ;;^UTILITY(U,$J,358.3,13224,2)
 ;;=^276301
 ;;^UTILITY(U,$J,358.3,13225,0)
 ;;=356.9^^65^784^37
 ;;^UTILITY(U,$J,358.3,13225,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13225,1,3,0)
 ;;=3^Periph Neuropathy
 ;;^UTILITY(U,$J,358.3,13225,1,4,0)
 ;;=4^356.9
 ;;
 ;;$END ROU IBDEI0RE
